InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 10/24/2012

Re: Whosetosay post# 30644

Thursday, 05/23/2013 4:55:51 PM

Thursday, May 23, 2013 4:55:51 PM

Post# of 80490
Institutional's are buying because Lazard Capital Market reported yesterday very good data from Ponatinib frontline therapy of PH+ ALL, the data will be presented at the ASCO
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.